Toivoa wins local Startup302 contest award
Share
WILMINGTON – After an extensive career in sales and C-suite positions at biotech and pharmaceutical companies including Regeneron Pharmaceuticals, one of the owners of the smash eczema drug Dupixent, Laura Randa is now taking a leadership role in a new company hoping to connect people with disabilities with the mental health care they need. Randa’s
Want to Read More?
Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.
Already an Insider? Log In.